Abstract
Twenty-one Lactobacillus isolates from "Sha'a" (a maize - based fermented beverage) and "Kossam" (traditionally fermented cow milk) were selected in accordance with their antagonistic activities and tested for their bacterio-cinogenic potential as well as safety properties. These isolates were preliminarily identified as Lactobacillus plantarum (62%), Lactobacillus rhamnosus (24%), Lactobacillus fermentum (10%) and Lactobacillus coprophilus (4%) based on phenotypic characteristics and rep-PCR genomic fingerprinting. Twelve (57.1%) out of the 21 strains tested were found to be bacteriocin producers, as revealed by the sensitivity of their antimicrobial substances to proteolytic enzymes (Trypsin, Proteinase K) and inhibition of other Lactobacillus spp. These bacteriocinogenic strains showed no positive haemolytic and gelatinase activities and proved to be sensitive to penicillin G, ampicillin, tetracycline, erythromycin, amoxicillin, chloramphenicol, co-trimoxazole and doxycyclin, but resistant to ciprofloxacin and gentamicin. The bacteriocins showed a broad inhibitory activity against Gram-positive and Gram-negative pathogenic bacteria, several of which are classified as especially dangerous by the World Health Organization, as well as Multidrug-resistant strains. These include Staphylococcus aureus, Salmonella enterica subsp. enterica serovare Typhi, Bacillus cereus, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Shigella flexneri. These Lactobacillus strains are promising candidates for use as protective cultures in food fermentation.
Keywords
Sha'a * Kossam * Lactobacillus spp. * Rep-PCR * Safety properties * Antimicrobial activity
Introduction
Lactic acid bacteria (LAB) have been used in the processing of fermented foods for centuries [1]. They are part of the daily diet of virtually all people around the world. Most often, production of indigenous fermented foods depends on naturally occurring LAB. They have the ability to produce a variety of antimicrobial substances such as organic acids, hydrogen peroxide and bacteriocins. Bacteriocins produced by LAB are ribosomally synthesized extracellular small peptides that exhibit bactericidal or bacteriostatic activity against genetically closely related bacteria [2]. They are the most important, because, due to their proteinaceous nature, they are rapidly digested by proteases in human and animal gastrointestinal tracts, unlike current antibiotics [3]. Given that the prevalence of multidrug-resistant (MDR) and especially dangerous pathogenic bacteria is increasing at an alarming rate [4], bacteriocins or bacteriocin-like substances could be a novel approach for an effective drug. In addition, fermented foods are also associated with LAB which possess remarkable properties for their use as starter cultures or probiotics. They are usually used for their health benefits in animal or human, and it is recommended that antibiotic resistance patterns and opportunistic virulence properties should be tested to document their safety [5]. In fact, antibiotic-resistant LAB could horizontally transfer their genes or determinants to opportunistic pathogens within the gut microbiota [6].
In the western highlands region of Cameroon, two traditional fermented foods named "Kossam" (fermented cow milk) and "Sha'a" (a maize-based beverage) are widely produced and consumed. While they constitute a natural reservoir of LAB which have not yet been identified and studied for their antimicrobial activity, there is obvious evidence that LAB strains from different origins could possess antimicrobial activities at different levels. It became important to initiate comprehensive studies to screen antimicrobial and safety properties of the wild LAB microbiota from these natural reservoirs for their antimicrobial applications. This research is important in order to valorise indigenous strains and also to propose another alternative to satisfy the increasing request of the market with novel bacteriocinogenic characterized LAB strains.
In the present study, lactobacilli with antagonistic activity isolated from "Kossam" and "Sha'a" were characterized and identified. They were also evaluated for bacteriocin production as well as some safety properties such as antibiotic susceptibility, haemolysis and gelatinase activities.
Results and Discussion
Isolation of Lactobacillus strains and inhibitory activity
A total of 90 Lactobacillus isolates was obtained. Sixty (75%) out of the 90 isolates inhibited the growth of the other lactobacilli strains, as well as Staphylococcus aureus ATCC25923, Salmonella enterica subsp. enterica serovare Typhi ATCC6539, Pseudomonas aeruginosa ATCC27853, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Shigella flexneri. From these 60 isolates, 21 (35%) with largest spectra and zone of inhibition were selected and used for further assays.
Preliminary identification of strains
The microscopic examination reveals that the tested isolates have cellular rod form, associated in pairs, heap or chain. In addition, all the isolates were found to be grampositive and catalase-negative. Based on the fermentative profile, data from each isolate was compared with profiles obtained from recognized test organisms, and it was determined that the isolates can be classified as Lb. plantarum, Lb. rhamnosus, Lb. coprophilus and Lb. fermentum (Table 1).
From the 21 isolates tested and identified using phenotypic characteristics, 18 were identified by rep-PCR. The dendrogram generated from BOXA1R-PCR banding patterns are given in Figure 1. The isolates belonging to group II Lactobacillus spp. were classified into 2 clusters. Cluster 1 consisted of Lb. rhamnosus (1K, 1K1, 3K) at r = 69.5%, whereas cluster 2 grouped Lb. plantarum strains (1S, 2S, 3S, 4S, 5S, 6S, 7S, 8S, 9S, 10S, 11S, 15S, 16S) at r = 73.06% (Figure 1).
The isolates belonging to the Group III Lactobacillus spp (13S, 2K) were similar to strains of Lb. fermentum at r = 68.8%. The strains of each cluster also showed characteristic banding pattern with slight differences, demonstrating their close relatedness. The majority of Lactobacillus strains with antagonistic activity was found in "Sha'a" where a predominance of Lactobacillus plantarum was observed, whereas in "Kossam", Lactobacillus rhamnosus was predominant. This result is in accordance with recent investigations showing that LAB with antagonistic activities are largely distributed in cerealbased fermented foods [21, 22]. Rep-PCR confirms all phenotypic results, except for one strain (13S). After identification by API system this strain has higher percent similarity with Lactobacillus coprophilus than Lactobacillus fermentum, but it was identified as Lactobacillus fermentum by rep-PCR. Such situations were also found by authors such as Chagnaud et al. [23], Mohamed et al. [9] and Terzic-Vidojevic et al. [24]. This shows that phenotypic tests sometimes suffer from lack of reproducibility and discriminatory power.
Screening for bacteriocin producing strains
Using combination of Triple-agar layer method and AWDA, 12 (57.1%) out of the 21 strains tested were found to be bacteriocin producers. Complete inactivation was observed when the CFS were treated by proteolytic enzymes, thus confirming the proteinaceous nature of the inhibitory substances. Treatment with α-Amylase and Lipase did not affect the antimicrobial activity, suggesting that the bacteriocins are not attached to carbohydrate or lipid moieties (Table 2 and Figure 2).
Inhibition of sensitive strain of Lactobacillus plantarum confirmed that the inhibitory substances were bacteriocins. This study reports for the first time the characterization of bacteriocin-producing LAB isolated from "Sha'a" and traditionally fermented cow milk from Cameroon. Although many studies reported bacteriocin production by LAB worldwide, few strains of Lactobacillus fermentum were listed [25, 26].
Safety attributes of bacteriocin-producing strains
All 12 strains assayed showed no positive haemolysis and gelatinase activity. With respect to haemolysis activity, these strains were found to be γ-haemolytic. Results of the antibiotic susceptibility of strains are listed in Tables 3 and 4.
Based on the disc diffusion test results, all the strains (100%) were susceptible to inhibitors of the cell wall synthesis (penicillin G, ampicillin and amoxicillin); they were also all susceptible to chloramphenicol and erythromycin. Sixty-six percent showed moderate susceptibility to tetracycline and doxycyclin, whereas 50% were resistant to gentamicin as far as inhibitors of protein or mRNA synthesis were concerned. The strains showed susceptibility (50%) and moderate susceptibility (50%) to co-trimoxazole, but were all resistant (100%) to ciprofloxacin, these antibiotics belonging to the group of nucleic acid synthesis's inhibitors.
With regard to MIC results, the strains showed resistance (100%) only to gentamicin as revealed by the comparison with the EFSA's breakpoints. According to the ISO's epidemiological cut-off values, two out of the 10 Lb. plantarum strains were recorded with MICs for ciprofloxacin above the quality control (QC) range. For all the Lb. rhamnosus strains, only the MICs for gentamicin and ciprofloxacin were above the QC range. Safety is one of the recommended attributes in guidelines on evaluation for probiotics and other LAB to be used as food additives [5]. Haemolysis activity would break down the epithelial layer while gelatinase activity would derange the mucoid lining interfering with the normal functioning of these very important linings across which many physiological substances are exchanged and would cause pathways for infections. None of the strains showed haemolysis or gelatinase activity, and these results were in accordance with those of Kalui et al. [27] for Lb. plantarum strains, Lb. rhamnosus strains and Enterococcus faecium ET05. A key requirement for these food additives LAB strains is that they should not carry transferable antibiotic resistance genes. Transferable resistance genes may pose a risk, as they can be transferred to pathogenic bacteria [28]. From the 10 antibiotics tested, some strains were found to be resistant only to two of them, ciprofloxacin and gentamicin. Such cases were also reported by other authors such as Elkins and Mullins, [29]; Herreros et al [30]; Rojo-Bezares et al. [31] who found resistance of Lactobacilli to ciprofloxacin, gentamicin and other aminoglycosides. These resistances are natural and intrinsic resistances, probably due to cell wall structure and membrane impermeability, complemented in some cases by potential efflux mechanisms. Intrinsic resistance is not horizontally transferable and poses no risk in non-pathogenic bacteria [32]. Furthermore, following the EUCAST definition of an epidemiological value [20], our strains can be categorized as wild type organisms (free of acquired and mutational resistance mechanisms). Therefore, all the strains tested in our study are considered to be safe.
Spectrum of Inhibitory activity
The inhibitory spectrum of the bacteriocins produced by selected strains is presented in Table 5.
The bacteriocins showed a relatively wide inhibition spectrum, inhibiting the growth of a number of Gram-positive and Gram-negative bacteria including species of the genera Lactobacillus, Streptococcus, Salmonella, Shigella, Bacillus, Staphylococcus, Escherichia, Pseudomonas and Klebsiella. However, no activity was detected against many other Lactobacillus strains and the Enterococcus faecium strain tested. Interestingly, some bacteriocins were active against multidrug-resistant (MDR) strains of S. aureus and E. coli. Multidrug-resistant bacteria have emerged as serious pathogens over the past decade and, despite major research efforts aimed at finding an effective drug, increasing resistance has compromised therapy [33].
Experimental
Samples, bacterial strains and growth conditions.
Fifteen and 20 samples respectively of "Kossam" and "Sha'a" were collected directly and aseptically from local producers in three localities of Cameroon's western highlands region. For lactic acid bacteria isolation, 1% (v/v) of each sample added to MRS broth (de Man Rogosa and Sharpe, Biolife, Milano, Italy) and incubated for 24 h at 30 °C was used to streak the surface of MRS agar plates. The plates were then incubated anaerobically (Genbox anaer; BioMérieux, France) at 30 °C for 48 h. Well-developed individual colonies on these plates were randomly picked and purified on MRS agar. These isolates were characterized based on the morphological characteristics, gram staining and catalase reaction [7]. The lactobacilli strains were kept in MRS broth plus glycerol (70:30) at -20 °C and were subcultured two times in MRS broth for activation prior to experimental use.
The reference strains for Rep - PCR analysis were obtained from Institut National de Recherche Agronomique (INRA), Centre de Recherche Zootechnique Jouy - en Josas, France (CNRZ) and American Type Culture Collection (ATCC).
Food borne spoilage and pathogenic bacteria (Proteus mirabilis and those listed in Table 5) used as indicator in testing antimicrobial activity were cultured at 37 °C and maintained on Mueller Hinton Agar (MHA, Conda, Madrid, Spain) slants.
Inhibition of the growth of other lactobacilli and pathogenic bacteria
The LAB isolates were tested for inhibition of the growth of other lactobacilli and some pathogenic bacteria using the spot on the lawn test as described by Geis et al. [8]. An aliquot (2 µl) of an overnight LAB culture was spotted onto MRS agar plates and incubated anaerobically at 30 °C for 48 h. The plates were subsequently overlaid with soft MRS agar (0.75% agar) or soft MHA containing 1% indicator strains, respectively, and then incubated anaerobically at 30 °C or aerobically at 37 °C, on the basis of the tested organisms, for 24 h. Only isolates showing the largest inhibition diameter zones were selected for the next steps.
Strains identification using physiological and biochemical methods
The 21 selected isolates were identified to species level using their carbohydrate pattern obtained with API 50 galleries (BioMérieux, Marcy l'Etoile France). Tests were performed according to the manufacturer's instructions. Interpretations of the fermentation profiles were facilitated by systematically comparing all results obtained from the isolates studied with information from the computer-aided database APILAB plus V.3.2.2.
Rep-PCR genomic fingerprinting
Total DNA was extracted from 1.6 ml of fresh cultures in the exponential growth phase using the Wizard DNA purification Kit as described by the manufacturer (Promega). Amplification of DNA and separation of PCR products were performed according to the method described by Mohammed et al. [9]. The Rep profiles were processed using the Gel Compar version 5.00 software (Applied Maths, Kortrijk, Belgium).
Screening of Lactobacillus strains for bacteriocin production
The Lactobacillus strains were screened for bacteriocin production using the Triple-agar layer method described by Todorov and Dicks [10], with the difference that buffered MRS medium (0.2 M potassium phosphate buffer, pH 7.0) was used and no antibiotic was added.
Cell-free supernatants (CFS) of the selected producer strains were screened for bacteriocin activity by the agar well diffusion assay (AWDA) as described by Schillinger and Lücke [11]. A 15-h-old culture (2% v/v) of each lactobacilli strain was inoculated in buffered MRS broth and incubated anaerobically at 30 °C for 10 h. The cultures were centrifuged (7,000 rpm, 30 min, 4 °C) and the supernatants collected, treated at 80 °C for 10 min [12] and then tested for their activity by the AWDA. In another set of experiments, the CFS were incubated for 2 h at 37 °C in the presence of 1.0 mg/ml (final concentration) of Trypsin (in 0.05 M Tris-HCl buffer, pH 8.0, Fluka Biochemika), Proteinase K (in 0.05 M phosphate buffer, pH 7.0, Merck) α-Amylase (in 0.05 M phosphate buffer, pH 7.0, Sigma-Aldrich), Lipase (in 0.05 M phosphate buffer, pH 7.0, Sigma-Aldrich) and Lysozyme (in 0.05 M phosphate buffer, pH 7.0, Fluka Biochemika) and then tested for antimicrobial activity by AWDA.
Safety attributes of bacteriocin-producing strains
The safety attributes studied were haemolytic activity, gelatinase activity and antibiotic susceptibility.
Haemolytic activity was investigated as described by Gerhardt et al. [13]. A 16-hour-old broth culture was streaked onto sterile blood agar plates. Plates were incubated anaerobically at 30 °C for 48 h. The haemolytic reactions were recorded by observation of a clear zone around the colonies (β-haemolysis), a partial hydrolysis and greening zone (α-haemolysis) or no reaction (γ-haemolysis) [14].
Gelatinase activity was investigated as described by Harrigan and Mc Cance [15]. A 16-hour-old culture was streaked onto nutrient gelatin agar (Oxoid). The plates were incubated anaerobically for 48 h at 30 °C after which they were flooded with a saturated ammonium sulfate solution and observed for clear zones surrounding colonies.
Antibiotic susceptibility was tested by disk diffusion and by broth micro-dilution methods [16-17], using LSM broth and agar as test media (LSM consists of a mixture of Iso-Sensitest medium, Oxoid Ltd). Incubation was done at 30 °C for 48 h. The MIC (µg/ml) was defined as the lowest antibiotic concentration that resulted in no visible growth. For disc diffusion antibiotic susceptibility, inhibition zone diameters (IZD) were measured and strains were classified as sensitive (IZD ≥ 21mm), intermediate (16mm ≤ IZD ≤ 20mm), and resistant (IZD ≤ 15mm) according to interpretative standards defined by CLSI [18] and Vlková et al. [19]. The MICs (µg/ml) were determined and the results of susceptibility status were interpreted according to the recent FEEDAP document of the European Food Safety Authority (EFSA) on the update of the criteria used in the assessment of antibiotics bacterial resistance of human or veterinary importance [5] as well as epidemiological cut-off values defined by the ACE - ART Project results, ISO 10932 [20]. Strains showing MICs less than EFSA's breakpoints were considered sensitive; otherwise, they were resistant. The following antibiotics obtained from Oxoid were tested: penicillin G, ampicillin, ciprofloxacin, tetracycline, erythromycin, amoxicillin, gentamicin, chloramphenicol, co-trimoxazole, and doxycyclin.
Spectrum of inhibitory activity of bacteriocin-producing strains
The antibacterial activities of the samples were tested against Gram-positive and Gramnegative bacteria (listed in table 5). The indicator strains (0.5 Mc Farland suspensions) were inoculated in the appropriate soft agar media and the antibacterial activities were determined by AWDA. Experiments were conducted in triplicate.
Acknowledgement
This study received the financial supports of the AUF Central Africa Regional office and TWAS. The authors thank the research assistants of the Microbial Biochemistry Laboratory (University of Alexandria-Egypt) for their helpful assistance during the identification of LAB, and ICCBS, University of Karachi-Pakistan for Laboratory facilities during screening for bacteriocin-producing strains.
Authors' Statement
Competing Interests
The authors declare no conflict of interest.
References
[1] Marteau P, Rambaud JC.
Potential of using lactic acid bacteria for therapy and immunomodulation in man.
FEMS Microbiol Rev. 1993; 12: 207-220.
http://dx.doi.org/10.1111/j.1574-6976.1993.tb00019.x
[2] Klaenhammer TR.
Bacteriocins of lactic acid bacteria.
Biochimie. 1988; 70: 337-349.
http://dx.doi.org/10.1016/0300-9084(88)90206-4
[3] Bromberg R, Moreno I, Zaganini CL, Delboni RR, De Oliveira J.
Isolation of bacteriocin-producing lactic acid bacteria from meat and meat products and its spectrum of inhibitory activity.
Braz J Microbiol. 2004; 35: 137-144.
http://dx.doi.org/10.1590/S1517-83822004000100023
[4] Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M.
Antibiotic resistance - the interplay between antibiotic use in animals and human beings.
Lancet Infect Dis. 2003; 3: 47-51.
http://dx.doi.org/10.1016/S1473-3099(03)00490-0
[5] EFSA.
Technical guidance. Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance.
The EFSA Journal. 2008; 732: 1-15.
[6] Klein G, Hallmann C, Casas IA, Abad J, Louwers J, Reuter G.
Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods.
J Appl Microbiol. 2000; 89: 815-824.
http://dx.doi.org/10.1046/j.1365-2672.2000.01187.x
[7] Harrigan WF, Mc Cance ME.
Laboratory methods.
In: Food and Dairy Microbiology.
Harigan WF, Mc Cance ME; eds.
Academic press. New York, USA. 1976: 12-15.
[8] Geis A, Singh J, Teuber M.
Potential of lactic streptococci to produce bacteriocin.
Appl Environ Microbiol. 1983; 45: 205-211.
http://www.ncbi.nlm.nih.gov/pubmed/16346166
[9] Mohammed M, Abd El-Aziz H, Omran N, Anwar S, Awad S, El-Soda M.
Rep-PCR characterization and biochemical selection of lactic acid bacteria isolated from the Delta area of Egypt.
Int J Food Microbiol. 2009; 128: 417-423.
http://dx.doi.org/10.1016/j.ijfoodmicro.2008.09.022
[10] Todorov SD, Dicks LMT.
Lactobacillus plantarum isolated from molasses produces bacteriocins active against Gram-negative bacteria.
Enz Microb Technol. 2005; 36: 318-326.
http://dx.doi.org/10.1016/j.enzmictec.2004.09.009
[11] Schillinger U, Lücke F.
Antibacterial activity of Lactobacillus sake isolated from meat.
Appl Environ Microbiol. 1989; 55: 1901-1906.
http://www.ncbi.nlm.nih.gov/pubmed/2782870
[12] Todorov SD, Dicks LMT.
Bacteriocin production by Pediococcus pentosaceus isolated from marula (Scerocarya birrea).
Int J Food Microbiol. 2009; 132: 117-126.
http://dx.doi.org/10.1016/j.ijfoodmicro.2009.04.010
[13] Gerhardt P, Murray RG, Costilow RN, Nester EW, Wood WA, Krieg NR, Phillips GB.
Manual of methos for general bacteriology.
American society for Microbiology, Washington, DC 20006. 1981.
[14] De Vuyst L, Foulquie Moreno MR, Revets H.
Screening for enterocins and detection of hemolysin and vancomycin resistance in enterococci of different origins.
Int J Food Microbiol. 2003; 84: 299-318.
http://dx.doi.org/10.1016/S0168-1605(02)00425-7
[15] Harrigan WF, Mc Cance ME.
Laboratory Methods in Food and Dairy Microbiology.
Academic Press, London. 1990.
[16] Clinical and Laboratory Standards Institute.
Performance standards for antimicrobial disc susceptibility test; Approved standard-Tenth Edition.CLSI document M02-A10 (ISBN 1-56238-688-3). Clinical and Laboratory Standards Institute, 940 West Valley Road, suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009.
[17] Clinical and Laboratory Standards Institute.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-Eight Edition. CLSI document M07-A8 (ISBN 1-56238-689-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009.
[18] Clinical and Laboratory Standards Institute.
Performance standards for antimicrobial susceptibility testing. Twenty-First Informational Supplement". CLSI document M100-S21. Wayne, PA; Clinical and Laboratory Standards Institute, 2011.
[19] Vlková E, Rada V, Popelárová P, Trojanová I, Killer J.
Antimicrobial susceptibility of bifidobacteria isolated from gastrointestinal tract of calves.
Livest Sci. 2006; 105: 253-259.
http://dx.doi.org/10.1016/j.livsci.2006.04.011
[20] ISO 10932 / IDF 223. Milk and milk products - Determination of minimal inhibitory concentration (MIC) of antibiotics applicable to bifidobacteria and non-enterococcal lactic acid bacteria (LAB). 2010.
[21] Diop MB, Dubois-Dauphin R, Tine E, Ngom A, Destain J, Thonart P.
Bacteriocin producers from traditional food products.
Biotechnol Agron Soc Environ. 2007; 11: 275-281.
[22] Todorov SD.
Bacteriocin production by Lactobacillus plantarum AMA-K isolated from Amasi, a Zimbabwean fermented milk product and study of adsorption of bacteriocin AMA-K to Listeria spp.
Braz J Microbiol. 2008; 38: 178-187.
http://dx.doi.org/10.1590/S1517-83822008000100035
[23] Chagnaud P, Machinis K, Coutte LA, Marecat A, Mercenier A.
Rapid PCR-based procedure to identify lactic acid bacteria: application to six common Lactobacillus species.
J Microbiol Methods. 2001; 44: 139-148.
http://dx.doi.org/10.1016/S0167-7012(00)00244-X
[24] Terzic-Vidojevic A, Tolinacki M, Nikolic M, Lozo J, Begovic J, Gulahmadov SG, Kuliev AA, Dalgalarrondo M, Chobert JM, Haertlé T, Topisirovic L.
Phenotypic and genotypic characterization of lactic acid bacteria isolated from Azerbaijani traditional dairy products.
Afr J Biotechnol. 2009; 8: 2576-2588.
[25] Todorov SD, Prévost H, Lebois M, Dousset X, Le Blanc JG, Franco BD.
Bacteriocinogenic Lactobacillus plantarum ST16Pa isolated from papaya (Carica papaya) - From isolation to application: Characterization of a bacteriocin.
Food Res Inter. 2011; 44: 1351-1363.
http://dx.doi.org/10.1016/j.foodres.2011.01.027
[26] Anas M, Jamal H, Eddine, Mebrouk K.
Antimicrobial activity of Lactobacillus species isolated from Algerian raw Goat's milk against Staphylococcus aureus.
World J Dairy Food Sci. 2008; 3: 39-49.
[27] Kalui CM, Mathara JM, Kutima PM, Kiiyukia C, Wongo LE.
Functional characteristics of Lactobacillus plantarum and Lactobacillus rhamnosus from ikii, a Kenyan traditional fermented maize porridge.
Afr J Biotechnol. 2009; 8: 4363-4373.
[28] Comunian R, Daga E, Dupré I, Paba A, Devirgiliis C, Piccioni V, Perozzi G, Zonenschain D, Rebecchi A, Morelli L, De Lorentiis A, Giraffa G.
Susceptibility to tetracycline and erythromycin of Lactobacillus paracasei strains isolated from traditional Italian fermented foods.
Int J Food Microbiol. 2010; 138: 151-156.
http://dx.doi.org/10.1016/j.ijfoodmicro.2009.11.018
[29] Elkins CA, Mullis LB.
Bile-mediated aminoglycoside sensibility in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid.
Appl Environ Microbiol. 2004; 70: 7200-7209.
http://dx.doi.org/10.1128/AEM.70.12.7200-7209.2004
[30] Herreros MA, Fresno JM, Sandoval H, Gonzáles L, Castro JM, Tornadijo ME.
Antimicrobial activity and antibiotic resistance of lactic acid bacteria isolated from Armada cheese (a Spanish goats' milk cheese).
Food Microbiol. 2004; 22: 455-459.
http://dx.doi.org/10.1016/j.fm.2004.11.007
[31] Rojo-Bezares B, Sáenz Y, Poeta P, Zarazaga M, Ruiz-Larrea F, Torres C.
Assessment of antibiotic susceptibility within lactic acid bacteria strains isolated from wine.
Int J Food Microbiol. 2006; 111: 234-240.
http://dx.doi.org/10.1016/j.ijfoodmicro.2006.06.007
[32] Mathur S, Singh R.
Antibiotic resistance in food lactic acid bacteria - A review.
Int J Food Microbiol. 2005; 105: 281-295.
http://dx.doi.org/10.1016/j.ijfoodmicro.2005.03.008
[33] French GL.
Bactericidal agents in the treatment of MRSA infections-the potential role of daptomycin.
J Antimicrob Chemother. 2006; 58: 1107-1117.
http://dx.doi.org/10.1093/jac/dkl393
Pierre Marie KAKTCHAM 1,2, Ngoufack François ZAMBOU * 1, Félicité Mbiapo TCHOUANGUEP 1, Morsi EL-SODA 3, Muhammad Iqbal CHOUDHARY 2
1 Laboratory of Biochemistry, Food Science and Nutrition (LABPMAN), Department of Biochemistry, Faculty of Science, University of Dschang, P.O. Box 67 Dschang, Cameroon.
2 HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi-75270, Pakistan.
3 Laboratory of microbial Biochemistry, Faculty of Agronomy, University of Alexandria, Egypt.
* Corresponding author. E-mail: [email protected] (N. F. Zambou)
Sci Pharm. 2012; 80: 189-203 doi:10.3797/scipharm.1107-12
Published: December 18th 2011 Received: July 11th 2011
Accepted: December 18th 2011
This article is available from: http://dx.doi.org/10.3797/scipharm.1107-12
© Kaktcham et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Österreichischer Apotheker-Verlagsgesellschaft m.b.H (Austrian Pharmacists' Publishing House) 2012